Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects

Scandinavian Journal of Gastroenterology

Volumn 51, Issue 4, 2016, Pages 410-419

  Chung, Chen Shuan ^a,b,c   Chang, Pi Feng ^a,d   Liao, Chun Hsing ^a   Lee, Tzong Hsi ^a   Chen, Yun ^a   Lee, Yi Chia ^e   Wu, Ming Shiang ^e   Wang, Hsiu Po ^e   Ni, Yen Hsuan ^e  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c Taiwan Association for the Study of Small Intestinal Diseases   (Taiwan)

^d ORIENTAL INSTITUTE OF TECHNOLOGY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Enteroscopy; irritable bowel syndrome; microbiota; next generation sequencing; small bowel

Indexed keywords

ACIDAMINOCOCCACEAE; ACTINOBACTERIA; ADULT; ARTICLE; BACTEROIDES; BACTEROIDETES; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIGESTIVE ENDOSCOPE; ESCHERICHIA; FAECALIBACTERIUM; FECES MICROFLORA; FEMALE; FIRMICUTES; FUSOBACTERIA; HELICOBACTER; HUMAN; HUMAN TISSUE; INTESTINE FLORA; IRRITABLE COLON; JEJUNUM BIOPSY; JEJUNUM MUCOSA; KLEBSIELLA; MALE; MYCOBACTERIACEAE; NEISSERIA; NEISSERIACEAE; NEXT GENERATION SEQUENCING; PREVOTELLA; PREVOTELLACEAE; PRIORITY JOURNAL; PROTEOBACTERIA; QUALITY CONTROL; SINGLE BALLOON ENTEROSCOPY; SMALL INTESTINE; STREPTOCOCCUS; CASE CONTROL STUDY; FECES; MICROBIOLOGY; MICROFLORA;

ADULT; CASE-CONTROL STUDIES; FECES; FEMALE; HUMANS; INTESTINE, SMALL; IRRITABLE BOWEL SYNDROME; MALE; MICROBIOTA;

EID: 84955185419     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2015.1116107     Document Type: Article

References (39)

1. Drossman DA, Corazziari E, Delvaux M, et al. Rome III diagnostic criteria for functional gastrointestinal disorders. Rev Gastroenterol Mex. 2010;75:511-516
2. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130: 1466-1479
3. Thompson WG, Heaton KW. Functional bowel disorders in apparently healthy people. Gastroenterology. 1980;79:283-288
4. Bassett JT, Cash BD. A review of irritable bowel syndrome and an update on therapeutic approaches. Expert Opin Pharmacother. 2008;9:1129-1143
5. Barbara G, De Giorgio R, Stanghellini V, et al. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther. 2004;20:1-9
6. Lee BJ, Bak YT. Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil. 2011;17:252-266
7. Yamini D, Pimentel M. Irritable bowel syndrome and small intestinal bacterial overgrowth. J Clin Gastroenterol. 2010;44:672-675
8. Dupont HL. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Aliment Pharmacol Ther. 2014;39:1033-1042
9. Kerckhoffs AP, Ter Linde JJ, Akkermans LM, et al. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Neurogastroenterol Motil. 2008;20:900-907
10. Helander HF, Fändriks L. Surface area of the digestive tract-revisited. Scand J Gastroenterol. 2014;49:681-689
11. Dlugosz A, Winckler B, Lundin E, et al. No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls. Sci Rep. 2015;5:8508. doi: 10.1038/srep08508
12. Huang WW, Zhou FS, Bushnell DM, et al. Cultural adaptation and application of the IBS-QOL in China: a disease-specific quality-of-life questionnaire. Qual Life Res. 2007;16:991-996
13. Ghoshal UC. How to interpret hydrogen breath tests. J Neurogastroenterol Motil. 2011;17:312-317
14. Chandra S, Dutta U, Noor MT, et al. Endoscopic jejunal biopsy culture: a simple and effective method to study jejunal microflora. Indian J Gastroenterol. 2010;29:226-230
15. Kerckhoffs AP, Samsom M, van der Rest ME, et al. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol. 2009;15:2887-2892
16. Giamarellos-Bourboulis E, Tang J, Pyleris E, et al. Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome. Scand J Gastroenterol. 2015;50:1076-1087
17. Abbasian F, Saberbaghi T. Metagenomic study of human gastrointestinal tracts in health and diseases. J Gastroenterol Hepatol Res. 2013;2:885-896
18. Scanu AM, Bull TJ, Cannas S, et al. Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities. J Clin Microbiol. 2007;45:3883-3890
19. Halvorson HA, Schlett CD, Riddle MS. Postinfectious irritable bowel syndrome - A meta-analysis. Am J Gastroenterol. 2006;101:1894-1899 (quiz 1942)
20. Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26:535-544
21. Sharara AI, Aoun E, Abdul-Baki H, et al. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol. 2006;101:326-333
22. Pimentel M, Park S, Mirocha J, et al. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med. 2006;145:557-563
23. Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364:22-32
24. Ghoshal UC, Srivastava D, Ghoshal U, et al. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. Eur J Gastroenterol Hepatol. 2014;26:753-760
25. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007;133:24-33
26. Malinen E, Rinttilä T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol. 2005;100:373-382
27. Mättö J, Maunuksela L, Kajander K, et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome - A longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol. 2005;43:213-222
28. Noor SO, Ridgway K, Scovell L, et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 2010;10:134
29. Rajilic-Stojanovic M, Biagi E, Heilig HG, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011;141:1792-1801
30. Rinttilä T, Lyra A, Krogius-Kurikka L, et al. Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects. Gut Pathog. 2011;3:6. doi: 10.1186/1757-4749-3-6
31. Tana C, Umesaki Y, Imaoka A, et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2010;22:512-519
32. Carroll IM, Chang YH, Park J, et al. Luminal and mucosalassociated intestinal microbiota in patients with diarrheapredominant irritable bowel syndrome. Gut Pathog. 2010;2:19. doi: 10.1186/1757-4749-2-19
33. Codling C, O'Mahony L, Shanahan F, et al. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci. 2010;55:392-397
34. Parkes GC, Rayment NB, Hudspith BN, et al. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterol Motil. 2012;24:31-39
35. Ringel Y, Maharshak N, Ringel-Kulka T, et al. High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals. Gut Microbes. 2015;6:173-181
36. Kleessen B, Kroesen AJ, Buhr HJ, et al. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol. 2002;37:1034-1041
37. Kumar PS, Griffen AL, Barton JA, et al. New bacterial species associated with chronic periodontitis. J Dent Res. 2003;82:338-344
38. Elinav E, Strowig T, Kau AL, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145:745-757
39. Wright DP, Rosendale DI, Robertson AM. Prevotella enzymes involved in mucin oligosaccharide degradation and evidence for a small operon of genes expressed during growth on mucin. FEMS Microbiol Lett. 2000;190:73-79